MMRGlobal Shareholder Update on MMR Patent Litigation LOS ANGELES, CA -- (Marketwired) -- 01/23/14 -- MyMedicalRecords Inc., a wholly owned subsidiary of MMRGlobal, Inc. (OTCQB: MMRF), (collectively, "MMR"), today announced that based on court filings dated January 21st 2014, MMR and Walgreen Co. are engaged in continuing settlement discussions pertaining to a "potential settlement or early resolution" to MMR's patent infringement complaints pertaining to MMR's U.S. Patent No. 8,301,466 and U.S. Patent No. 8,498,883 (the "883 Patent"). Walgreens and MMR filed a joint stipulation requesting an extension of time for Walgreens to respond to MMR's complaint involving MMR's '883 Patent, also referred to as United States District Court, Central District of California Case No.: CV-13-9214-ODW (SHx). The court filing states, amongst other things, that: "This Joint Stipulation Extending the Time to Respond to Plaintiff's Complaint by Not More Than 30 Days is made and entered into by and between Plaintiff MyMedicalRecords, Inc. ("MMR") and Defendant Walgreen Co. ("Walgreens"), by and through their respective counsel, with reference to the following facts: A. Whereas, on January 2, 2014, Plaintiff served its complaint on Walgreens. B. Whereas, the parties are continuing discussions regarding a potential settlement or early resolution of this matter. C. Whereas, the parties have agreed to extend Walgreens' time to respond to the complaint by fourteen (14) days to February 6, 2014." Earlier this week, MMR announced that it is being awarded its 10th U.S. patent from the United States Patent and Trademark Office, U.S. Patent No. 8,645,161 entitled "Method and System for Providing Online Records." MMRGlobal is a practicing entity and a leading provider of Personal Health Records ("PHRs") and MMRPro document management and imaging systems for health care professionals. This 10th and latest patent includes 30 claims directed toward utilizing phones, wireless and other web-enabled devices to allow for storing Personal Health Records in the form of voice mail, faxes, email, HL7 and other media pertaining to the receiving or sending of communications with health care providers, pharmacies and other health care professionals. Subject matter claimed also includes providing a user interface that collects and displays prescriptions while helping submit them to pharmacies. Additional claims allow users to annotate health records, and set up appointment reminders with providers as well as medication reminders through a built-in calendaring function, as well as the collection and display of health insurance information. The 10th patent adds to MMR's growing U.S. health IT patent portfolio which also includes 18 pending U.S. applications in addition to issued U.S. Patent Nos. 8,121,855; 8,117,045; 8,117,646; 8,301,466; 8,321,240; 8,352,287; 8,352,288; 8,498,883 and 8,626,532. The MMR patent portfolio also includes numerous issued patents and pending applications in other countries or regional authorities of commercial interest including Australia, Singapore, New Zealand, Mexico, Japan, Canada, China, Hong Kong, South Korea, Israel and Europe. Additional information can be found at: http://phx.corporate-ir.net/phoenix.zhtml?c=178404&p=irol-irhome About MMRGlobal MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. MMR's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, MMR acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId(TM)/Specifid(TM) vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of MMR's products and services at www.mmrtheater.com. Forward-Looking Statements All statements in this press release that are not strictly historical in nature, including, without limitation, intellectual property enforcement actions, infringement claims or litigation, intellectual property licenses, and future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause MMR's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "potential," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Actual outcomes and results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, monetize and protect our patent portfolio for both MMR's health IT and biotechnology intellectual property assets in the U.S. and internationally; the timing of milestone payments in connection with licensing our intellectual property; our ability to establish and maintain strategic relationships; changes in our relationships with our licensees; the risk MMR's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; the timing and volume of sales and installations; the length of sales cycles and the installation process; the market's acceptance of new product and service introductions; competitive product offerings and promotions; changes in government laws and regulations including the 2009 HITECH Act and changes in Meaningful Use and the 2010 Affordable Care Act; future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; the possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in MMR's filings with the Securities and Exchange Commission. MMR is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise. CONTACT: Michael Selsman Public Communications Co. email@example.com (310) 922-7033
MMRGlobal Shareholder Update on MMR Patent Litigation
Press spacebar to pause and continue. Press esc to stop.